Search

everythinglearnresearchcommunity

for

Search:↓

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Early hair loss may indicate prostate issues.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

New acne treatments show promise as alternatives to traditional therapies.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

No definitive link between finasteride and male breast cancer, but further research is needed.